These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19364501)

  • 1. Deamino-hydroxy-phoslactomycin B, a biosynthetic precursor of phoslactomycin, induces myeloid differentiation in HL-60 cells.
    Simizu S; Teruya T; Nogawa T; Aono H; Ueki M; Uramoto M; Kobayashi Y; Osada H
    Biochem Biophys Res Commun; 2009 Jun; 383(4):406-10. PubMed ID: 19364501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis of phoslactomycin A.
    König CM; Gebhardt B; Schleth C; Dauber M; Koert U
    Org Lett; 2009 Jul; 11(13):2728-31. PubMed ID: 19485355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantio- and stereoselective route to the phoslactomycin family of antibiotics: formal synthesis of (+)-fostriecin and (+)-phoslactomycin B.
    Sarkar SM; Wanzala EN; Shibahara S; Takahashi K; Ishihara J; Hatakeyama S
    Chem Commun (Camb); 2009 Oct; (39):5907-9. PubMed ID: 19787137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-stability study of phoslactomycin B and analysis of the acid and base degradation products.
    Choudhuri SD; Ayers S; Soine WH; Reynolds KA
    J Antibiot (Tokyo); 2005 Sep; 58(9):573-82. PubMed ID: 16323318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nargenicin enhances 1,25-dihydroxyvitamin D(3)- and all-trans retinoic acid-induced leukemia cell differentiation via PKCbetaI/MAPK pathways.
    Kim SH; Yoo JC; Kim TS
    Biochem Pharmacol; 2009 Jun; 77(11):1694-701. PubMed ID: 19428323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of phoslactomycin E as a metabolite inducing hyphal morphological abnormalities in Aspergillus fumigatus IFO 5840.
    Mizuhara N; Usuki Y; Ogita M; Fujita K; Kuroda M; Doe M; Iio H; Tanaka T
    J Antibiot (Tokyo); 2007 Dec; 60(12):762-5. PubMed ID: 18277002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 1-substituted 3-pyridinylmethylidenylindolin-2-ones and 1-substituted 3-quinolinylmethylidenylindolin-2-ones as the enhancers of ATRA-induced differentiation in HL-60 cells.
    Hung CY; Hsu MH; Huang LJ; Hwang CS; Lee O; Wu CY; Chen CH; Kuo SC
    Bioorg Med Chem; 2008 Apr; 16(8):4222-32. PubMed ID: 18346898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of DAAS derivatives and their enhancement of HL-60 leukemia cell differentiation.
    Kim SH; Chung SY; Kim YW; Kim TS; Choi BG
    Arch Pharm Res; 2008 Mar; 31(3):300-4. PubMed ID: 18409041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis of phoslactomycin B and its biosynthetic deamino precursor.
    Wang YG; Takeyama R; Kobayashi Y
    Angew Chem Int Ed Engl; 2006 May; 45(20):3320-3. PubMed ID: 16619316
    [No Abstract]   [Full Text] [Related]  

  • 10. Albidopyrone, a new alpha-pyrone-containing metabolite from marine-derived Streptomyces sp. NTK 227.
    Hohmann C; Schneider K; Bruntner C; Brown R; Jones AL; Goodfellow M; Krämer M; Imhoff JF; Nicholson G; Fiedler HP; Süssmuth RD
    J Antibiot (Tokyo); 2009 Feb; 62(2):75-9. PubMed ID: 19132055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell differentiation enhancement by hydrophilic derivatives of 4,8-dihydrobenzo[1,2-b:5,4-b']dithiophene-4,8-diones in HL-60 leukemia cells.
    Wen YF; Lee KH; Huang PT; Chen MH; Shin WC; Huang LJ; Hsu MH; Chen CJ; Kuo SC
    Bioorg Med Chem Lett; 2007 May; 17(10):2908-12. PubMed ID: 17336524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel microbial metabolites of the phoslactomycins family induce production of colony-stimulating factors by bone marrow stromal cells. II. Isolation, physico-chemical properties and structure determination.
    Kohama T; Nakamura T; Kinoshita T; Kaneko I; Shiraishi A
    J Antibiot (Tokyo); 1993 Oct; 46(10):1512-9. PubMed ID: 7503976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modular polyketide synthases and cis double bond formation: establishment of activated cis-3-cyclohexylpropenoic acid as the diketide intermediate in phoslactomycin biosynthesis.
    Alhamadsheh MM; Palaniappan N; Daschouduri S; Reynolds KA
    J Am Chem Soc; 2007 Feb; 129(7):1910-1. PubMed ID: 17256943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAT as a potential enhancer of monocytic differentiation: implications from the comparative proteome analysis of the HL60 cell line stimulated by all-trans retinoic acid and NSC67657.
    Wang W; Zhang X; Deng K; Huang S; Mao X; Fu Y; Yi Z; Yan Y; Qiu Z
    Cell Biochem Funct; 2009 Aug; 27(6):329-37. PubMed ID: 19569129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactomycins A-C, Dephosphorylated Phoslactomycin Derivatives that Inhibit Cathepsin B, from the Marine-derived Streptomyces sp. ACT232.
    Sun Y; Carandang RR; Harada Y; Okada S; Yoshitake K; Asakawa S; Nogi Y; Matsunaga S; Takada K
    Mar Drugs; 2018 Feb; 16(2):. PubMed ID: 29466301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment.
    Kittaka A; Hara H; Takano M; Sawada D; Arai MA; Takagi K; Chida T; Harada Y; Saito H; Takenouchi K; Ishizuka S; Hayashi K; Ikushiro S; Sakaki T; Sugiura T; Chen TC
    Anticancer Res; 2009 Sep; 29(9):3563-9. PubMed ID: 19667149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric total synthesis of (+)-phoslactomycin B.
    Shibahara S; Fujino M; Tashiro Y; Takahashi K; Ishihara J; Hatakeyama S
    Org Lett; 2008 Jun; 10(11):2139-42. PubMed ID: 18461955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNF4435C and D, novel immunosuppressants produced by a strain of Streptomyces spectabilis. I. Taxonomy, fermentation, isolation and biological activities.
    Kurosawa K; Takahashi K; Tsuda E
    J Antibiot (Tokyo); 2001 Jul; 54(7):541-7. PubMed ID: 11560371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.